0000-0002-4869-3198 About
Dr. Sanjukta Chakraborty is currently an Associate Professor in the Division of Lymphatic Biology, Department of Medical Physiology, School of Medicine at Texas A&M University Health Science Center, College Station, Texas. She received her Ph.D. in cancer genetics from the Indian Institute of Science, and completed her training as an American Heart Association Postdoctoral fellow in Lymphatic Biology at Texas A&M Health Science Center. Her research program encompasses key facets of basic cancer biology and translational drug discovery for lymph node metastatic tumors. Presence of tumor cells in the draining lymph nodes is a key indicator of disease aggressiveness and poor patient outcome. However, targeting of lymphatic metastatic cancers has been challenged by lack of focused therapies. By constantly innovating, the lab is accelerating an ambitious onco-lymphatic program and building a foundation of a rich pipeline of potential first- and best-in-class therapeutics. Dr. Chakraborty's research is funded by the American Heart Association, Cancer Prevention and Research Institute of Texas (CPRIT), and the National Institute of Health. She has received several scientific awards including the Microcirculatory Society Award for Excellence in Lymphatic Research, MCS Award for Outstanding Investigator, Outstanding Reviewer Award and has been nominated as a protégé to the Texas Academy of Medicine, Engineering, Science & Technology (TAMEST). She serves as an Associate Editor for Frontiers in Oncology and is on the editorial board of Scientific Reports. She also serves on several grant review panels and study sections as well as in national leadership roles, as a faculty representative to the Council of Faculty and Academic Societies (CFAS) and has been elected to the Executive Council of the Microcirculatory Society. She also serves as the Curriculum Director of the NIH T32 LYMPH Training Program that aims to mentor the next generation of lymphatic researchers.
Employment
-
Texas A&M Health Science Center Associate Professor2024 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (37)
- Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development. Save
- Hypertensive Stimuli Indirectly Stimulate Lymphangiogenesis through Immune Cell Secreted Factors Save
- FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis. Save
- Biliary Epithelial Senescence in Liver Disease: There Will Be SASP. Save
- Lymphangion-chip: a microphysiological system which supports co-culture and bidirectional signaling of lymphatic endothelial and muscle cells. Save
- Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer Save
- Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma Save
- Identification of miR-203a, mir-10a, and miR-194 as predictors for risk of lymphovascular invasion in head and neck cancers. Save
- Isolation of Lymphatic Muscle Cells (LMCs ) from Rat Mesentery. Save
- The β1 integrin plays a key role in lymphatic endothelial cell invasion in an optimized 3D Collagen matrix model. Save